Keywords: Ipsen, First-half 2011 financial esults, Partnership, Inspiration Biopharma, Hemophilia, Executive appointments

Ipsen leaps on strong first-half results; expands links with Inspiration Biopharma and names new CFO

Article | 31 August 2011

Print This

On a very busy news days for French drugmaker Ipsen (Euronext: IPN), the company saw its shares jump as much ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in